AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The National Institute of Health (NIH) announced last week it will award the Alzheimer's Disease Cooperative Study (ADCS) $52 million in funding over six years to conduct trials on novel treatments for Alzheimer's disease (AD), estimated to affect as many as 50 percent of Americans age 85 and older. New clinical drug trials to slow down the progression or treat the symptoms of AD will join ongoing studies, which …